Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing
TIMEX
1 other identifier
interventional
58
1 country
1
Brief Summary
The overall aim is to investigate effects of acute exercise on ad libitum energy intake and study whether this differs between morning and evening in individuals with overweight/obesity with or without type 2 diabetes (T2D). Furthermore, the aim is to examine the role of hedonic and homeostatic drivers of appetite control in obesity and T2D in the context of meal and exercise timing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 15, 2023
CompletedStudy Start
First participant enrolled
March 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedMay 30, 2025
May 1, 2025
1.4 years
February 15, 2023
May 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ad libitum energy intake (KJ) after exercise compared with rest
Food intake (KJ) is measured after meal completion, exercise compared with rest
Measured after meal consumption at t = 30 minutes
Secondary Outcomes (37)
Ad libitum energy intake (KJ) after exercise in the morning compared with evening
Measured after meal consumption at t = 30 minutes
Ad libitum energy intake (KJ) after rest in the morning compared with evening
Measured after meal consumption at t = 30 minutes
Eating pace (KJ/min)
Measured from start to finish of meal consumption at t = 15 minutes to end of meal, morning and evening, exercise and rest
Glucose (mmol/L)
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
Triglyceride (mmol/L)
Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest
- +32 more secondary outcomes
Study Arms (4)
Morning exercise
EXPERIMENTALStudy visit performed in the morning with 45 min exercise.
Morning control
EXPERIMENTALStudy visit performed in the morning with 45 min rest period.
Evening exercise
EXPERIMENTALStudy visit performed in the evening with 45 min exercise.
Evening control
EXPERIMENTALStudy visit performed in the evening with 45 min rest period.
Interventions
45 min exercise bout performed on bicycle ergometer. The exercise bout will consist of a 10 min warm-up period at 40 % Watt max followed by 4 cycles of 4 min at 85 % Watt max and 3 min at 50 % Watt max. A cool-down period (7 min) will be performed at 40 % Watt max.
45 min rest during the same time period as the exercise bout on exercise study visits.
Eligibility Criteria
You may qualify if:
- Adults with overweight or obesity (BMI \>25 kg/m2) with and without T2D
- HbA1c ≥48 mmol/mol for people with T2D
You may not qualify if:
- Not able to eat ad libitum meal
- Not able to perform the exercise bout
- Daily smoking
- For women: Pregnancy / planned pregnancy (within the study period) / lactating
- Self-reported history of an eating disorder in the past 3 years
- Treatment with antidepressants
- Treatment with fast acting insulin, combination insulin products and sulfonylureas
- Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, gastrointestinal, or psychiatric disease; diabetes or other endocrine disease; immunosuppression
- Current treatment with medication which significantly affect appetite or energy balance (e.g., GLP-1 receptor agonists)
- Bariatric surgery
- Unable to understand the informed consent and the study procedures
- Concomitant participation in intervention studies
- Incapable of understanding Danish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Steno Diabetes Center Copenhagenlead
- University of Leedscollaborator
- Novo Nordisk A/Scollaborator
Study Sites (1)
Steno Diabetes Center Copenhagen
Herlev, DK-2730, Denmark
Related Publications (1)
Jalking L, Launbo NP, Jensen MM, Pedersen HE, Blond MB, Gerstenberg MK, Finlayson G, Beaulieu K, Faerch K, Grunnet LG, Quist JS. Effects of exercise and exercise timing on energy intake and appetite control in Danish individuals with overweight or obesity with and without type 2 diabetes: a protocol for a randomised controlled cross-over trial. BMJ Open. 2025 Feb 6;15(2):e092683. doi: 10.1136/bmjopen-2024-092683.
PMID: 39915022DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristine Færch, PhD
Steno Diabetes Center Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2023
First Posted
March 15, 2023
Study Start
March 22, 2023
Primary Completion
August 21, 2024
Study Completion (Estimated)
July 31, 2026
Last Updated
May 30, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
Data from the trial will not be made publicly available as individual data from participants are protected by EU's GDPR (General Data Protection Regulation) laws and Danish Data Protection laws. Study results can be made available upon reasonable request from the corresponding author.